BioInvent International AB BOVNF:Grey Market

RT Quote | Exchange | USD
Last | 01/20/21 EST
6.51UNCH (UNCH)
52 week range
0.18 - 6.51

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close6.51
  • 52 Week High6.51
  • 52 Week High Date01/20/21
  • 52 Week Low0.18
  • 52 Week Low Date07/21/20
  • Market Cap225.11M
  • Shares Out39.38M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.48
  • P/E (TTM)-13.56
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest BioInvent International AB News

There is no recent news for this security.

Latest BOVNF News From Our Partners

QUOTE FINDER

Profile

MORE
BioInvent International AB is a Sweden-based biopharmaceutical company, that develops antibody-based drugs for cancer therapies, with two ongoing programs in Phase l/ll clinical trials for the treatment of haematological cancer and solid tumors. The Company’s operational activities are focused on expanding the clinical development of human antibodies, such as BI-1206, BI-1808, BI-1607 and BT-001. The Company has one wholly-owned subsidiary BioInvent Finans AB, which engaged...
Leonard Kruimer CPA
Chairman
Martin Welschof Ph.D.
President
Stefan Ericsson
Chief Financial Officer
Address
Ideon Science Park
Lund
223 70
Sweden